about
Regulation of vascular reactivity in scleroderma: new insights into Raynaud's phenomenonFunctional SNP of ARHGEF10 confers risk of atherothrombotic strokeRad GTPase deficiency leads to cardiac hypertrophyComparative gene expression profiling in three primary human cell lines after treatment with a novel inhibitor of Rho kinase or atorvastatinThe Trafficking of the Water Channel Aquaporin-2 in Renal Principal Cells-a Potential Target for Pharmacological Intervention in Cardiovascular DiseasesInnovative Target Therapies Are Able to Block the Inflammation Associated with Dysfunction of the Cholesterol Biosynthesis PathwayVascular endothelial dysfunction and pharmacological treatmentHuman isoprenoid synthase enzymes as therapeutic targetsA novel therapeutic effect of statins on nephrogenic diabetes insipidusThe Rho kinases: critical mediators of multiple profibrotic processes and rational targets for new therapies for pulmonary fibrosisStatin-Induced Increases in Atrophy Gene Expression Occur Independently of Changes in PGC1α Protein and Mitochondrial ContentHepatic and pulmonary toxicogenomic profiles in mice intratracheally instilled with carbon black nanoparticles reveal pulmonary inflammation, acute phase response, and alterations in lipid homeostasisSimvastatin restores down-regulated GATA-6 expression in pulmonary hypertensive ratsAtorvastatin at reperfusion reduces myocardial infarct size in mice by activating eNOS in bone marrow-derived cells.Statin post-treatment provides protection against simulated ischemia in bovine pulmonary arterial endothelial cells.Calcific aortic valve stenosis: methods, models, and mechanismsThe pleiotropic effects of simvastatin on retinal microvascular endothelium has important implications for ischaemic retinopathiesPhosphorylation of endothelial NOS contributes to simvastatin protection against myocardial no-reflow and infarction in reperfused swine hearts: partially via the PKA signaling pathway.Effect of pravastatin on echocardiographic circulation parameters in dogs.Functional characterization of the atypical integral membrane lipid phosphatase PDP1/PPAPDC2 identifies a pathway for interconversion of isoprenols and isoprenoid phosphates in mammalian cells.Pertussis toxin up-regulates angiotensin type 1 receptors through Toll-like receptor 4-mediated Rac activation.Mixed-lineage kinase 3 deficiency promotes neointima formation through increased activation of the RhoA pathway in vascular smooth muscle cellsSynergistic effects of matrix nanotopography and stiffness on vascular smooth muscle cell function.Increased finger skin vasoreactivity and stimulated vasomotion associated with simvastatin therapy in systemic sclerosis hypercholesterolemic patients.The xanthine derivative KMUP-1 inhibits models of pulmonary artery hypertension via increased NO and cGMP-dependent inhibition of RhoA/Rho kinaseReduced LDL-cholesterol levels in patients with coronary artery disease are paralleled by improved endothelial function: An observational study in patients from 2003 and 2007Spironolactone lowers portal hypertension by inhibiting liver fibrosis, ROCK-2 activity and activating NO/PKG pathway in the bile-duct-ligated rat.The effect of statin on epithelial-mesenchymal transition in peritoneal mesothelial cells.Novel therapeutic strategies for adult obese asthmatics.OxLDL-dependent activation of arginase II is dependent on the LOX-1 receptor and downstream RhoA signaling.Association analysis of polymorphisms in ROCK2 with cardiovascular disease in a Chinese population.Thy-1-induced migration inhibition in vascular endothelial cells through reducing the RhoA activityTherapeutic levels of the hydroxmethylglutaryl-coenzyme A reductase inhibitor lovastatin activate ras signaling via phospholipase D2.Atorvastatin upregulates regulatory T cells and reduces clinical disease activity in patients with rheumatoid arthritis.Sip1, an AP-1 accessory protein in fission yeast, is required for localization of Rho3 GTPase.Emerging concepts in liver graft preservationCombination of sildenafil and simvastatin ameliorates monocrotaline-induced pulmonary hypertension in rats.Increased availability of angiotensin AT 1 receptors leads to sustained arterial constriction to angiotensin II in diabetes - role for Rho-kinase activationSimvastatin enhances aquaporin-2 surface expression and urinary concentration in vasopressin-deficient Brattleboro rats through modulation of Rho GTPase.Relation of improvement in estimated glomerular filtration rate with atorvastatin to reductions in hospitalizations for heart failure (from the Treating to New Targets [TNT] study).
P2860
Q24170159-457CF6BE-E6F1-45D4-BA88-69EF31FC50CCQ24293564-E541718E-8D0C-448E-ADC9-0BBD1B31874EQ24302070-F4C32D6A-0C82-45EF-96F2-3754FDFAC79EQ24646870-2A0877E0-8BD1-41F3-B112-775D1C16CA79Q26768170-864C4105-B651-471C-9E05-2A7A50F32E42Q26771260-50EB5DEC-328C-478A-8F0D-3C0D91600337Q26774561-D9857A70-B0AB-4CD3-B5BE-A7F16467A3B3Q26822639-E24111CF-1AD5-450F-B7F8-C570FE8FF108Q27005638-98069505-8B23-40B2-BA67-9EFBA11B5DA1Q27005980-6A9E634B-80D1-439C-B977-0E178778BFB7Q27305332-B8481706-E6D0-4384-987E-027A43616926Q28384557-7EF4AEA8-9950-4706-9C06-29E2FF30C965Q28582463-17223494-D092-4648-B52D-86C37F296B46Q30301174-22453949-485E-4F07-B392-B24DC2AB557EQ30431767-4AA0AB41-029D-4886-9794-3B9054D73003Q30503246-EAA7528E-B1F8-4D64-849A-7DEC684A8F69Q33350185-21D4CD32-AC5B-46F0-8CF6-959649994DAEQ33570835-B71F27E5-1D34-4010-9518-05AA457CCAACQ33780370-9FE19EAB-AFF2-45EE-8EF2-ADEE7FA97CAEQ33810162-AA9C0F93-07E0-4803-B841-CD52B04CDF3FQ33832734-1DEC3970-E10C-41FF-9ABF-1E4985A7715DQ33855025-2E9454C3-D74B-4A4D-8C82-70DB894AC283Q34063661-62CA5BF0-82FD-49BD-9FAD-A1E3AD9754C1Q34068022-82AFCEC1-C09C-4A94-8059-3BB29C504D0CQ34112875-722724DA-20E4-4C46-A601-BD4E8B8B4E7CQ34159297-DF39CC4C-4FBF-4D89-B5EB-1EBF39FFC73BQ34222291-DB4D49E1-5C02-427C-ABB8-E81D9775879CQ34282610-01FABCB7-3237-4128-BF29-71AE150C69F2Q34290008-8EC922E2-499F-4662-9E1E-4A07E805AC9BQ34543359-7A19CEAE-917B-426C-9EA3-3E77F6E4FE1FQ34551911-E4EA40D3-E38F-4CFE-8D34-E5C17753AA80Q34684502-3CAB61B2-9C9C-4D65-B7D6-BA479B368ECEQ34742771-CCFDFF9F-61C4-4306-9CB8-7CADF30347F1Q34776189-3C0253D5-BE0D-498E-A4E6-3B5BF9165500Q34809203-52D62FC1-5ADB-499D-8074-38ED9B1A7CB1Q34932318-E2AB2444-6CE0-48AC-B3CA-8BC5B23B3C23Q35024562-7A89AC8C-53DD-4AAF-951E-2B9727E2302AQ35089880-E8571508-B8CB-4FE2-A8E4-8ED032D35A49Q35159559-08DA44FB-7580-4515-BFD7-B61D487CEEC7Q35679895-9E3303FC-04A7-4FC9-BC5F-234AFA39DF78
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Rho GTPases, statins, and nitric oxide.
@ast
Rho GTPases, statins, and nitric oxide.
@en
type
label
Rho GTPases, statins, and nitric oxide.
@ast
Rho GTPases, statins, and nitric oxide.
@en
prefLabel
Rho GTPases, statins, and nitric oxide.
@ast
Rho GTPases, statins, and nitric oxide.
@en
P2860
P1433
P1476
Rho GTPases, statins, and nitric oxide.
@en
P2093
James K Liao
Yoshiyuki Rikitake
P2860
P304
P356
10.1161/01.RES.0000196564.18314.23
P577
2005-12-01T00:00:00Z